Disease classification: A pitfall of the ERA/EDTA registry?

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1022-1024

  Ronco, Pierre ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

AMYLOIDOSIS; B LYMPHOCYTE; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; DIARRHEA; DISEASE CLASSIFICATION; DISEASE REGISTRY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPOTENSION; IMMUNOPATHOLOGY; KIDNEY INJURY; LIGHT CHAIN; LIGHT CHAIN DEPOSITION DISEASE; MULTIPLE MYELOMA; NOTE; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; REGISTRIES; RENAL DIALYSIS;

EID: 77950282832     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq022     Document Type: Note

References (12)

1. Defronzo RA, Humphrey RL, Wright JR, et al. Acute renal failure in multiple myeloma. Medicine 1975; 54: 209-223
2. Coward RA, Mallick NP, Delamore IW. Should patients with renal failure associated with myeloma be dialysed?. Br Med J 1983; 287: 1575-1578
3. Tsakiris DJ, Stel VS, Finne P, et al. Incidence and outcome of patients starting renal replacement therapy for end stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrol Dial Transplant 2009, in press
4. Abbott KC, Agodoa LY. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol 2001; 56: 207-210
5. Isaac J, Herrera GA. Cast nephropathy in a case of Waldenström's macroglobulinemia. Nephron 2002; 91: 512-515
6. Korbet SM, Schwartz MM. Multiple myeloma. J Am Soc Nephrol 2006; 17: 2533-2545
7. Iványi B. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990; 114: 986-987
8. Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983; 58: 665-683
9. Bollée G, Guery B, Joly D, et al. Presentation and outcome of patients with systemic amyloidosis undergoing dialysis. Clin JAm Soc Nephrol 2008; 3: 375-381
10. Ronco P, Aucouturier P. Renal involvement in AL amyloidosis: the facts, the promise and the hope. Nephrol Dial Transplant 2009; 24: 2967-2969
11. Gertz MA, Leung N, Lacy MQ, et al. Clinical outcome of immuno-globulin light chain amyloidosis affecting the kidney. Nephrol Dial Transplant 2009; 24: 3132-3137
12. Ronco P, Plaisier E, Mougenot B, et al. Immunoglobulin light (heavy)-chaindeposition disease:frommolecular medicinetopathophysiology-driven therapy. Clin J Am Soc Nephrol 2006; 1: 1342-1350